levamisole has been researched along with Local Neoplasm Recurrence in 66 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (34.85) | 18.7374 |
1990's | 20 (30.30) | 18.2507 |
2000's | 21 (31.82) | 29.6817 |
2010's | 1 (1.52) | 24.3611 |
2020's | 1 (1.52) | 2.80 |
Authors | Studies |
---|---|
Bernardi, S; Boyer, O; Charbit, M; Innocenti, S | 1 |
Dahl, O; Leh, S; Myklebust, MP; Stanisavljević, L | 1 |
Arkenau, HT; Bermann, A; Porschen, R; Rettig, K; Strohmeyer, G | 1 |
Cafiero, F; Gipponi, M; Lionetto, R | 1 |
Benson, AB; Catalano, PJ; Fuchs, CS; Haller, DG; Macdonald, JS; Mayer, RJ; Meyerhardt, JA | 1 |
Alberts, SR; Benedetti, J; Cha, SS; Chen, W; Francini, G; Francois Seitz, J; Gill, S; Goldberg, RM; Haller, DG; Heldebrant, MP; Labianca, R; Loprinzi, CL; Sargent, DJ; Shepherd, LE; Thomé, SD | 1 |
Gal, R; Klein, B; Koren, R; Sadikov, E; Sulkes, J | 1 |
Benson, AB; Donohue, JH; Fisher, B; Goldberg, RM; Gunderson, LL; Mailliard, JA; Martenson, JA; Myerson, R; Sargent, DJ; Thomas, CR; Willett, CG | 1 |
Balafouta, M; Dimitrakopoulos, A; Felekouras, E; Fotiadis, K; Gennatas, K; Gouveris, P; Karatzas, G; Kosmas, C; Kouraklis, G; Papalambros, E; Papastratis, G; Paraskevaidis, M; Safioleas, M; Skopelitis, HM; Tsavaris, N; Vasiliou, J; Voros, D; Zacharakis, M; Zografos, G | 1 |
Gnant, M; Hausmaninger, H; Hofbauer, F; Holzberger, P; Jagoditsch, M; Jakesz, R; Mischinger, HJ; Mittlböck, M; Mlineritsch, B; Schaberl-Moser, R; Schippinger, W; Sorré, C; Steger, G | 1 |
Catalano, PJ; Frontiera, MS; Haller, DG; Jackson, DV; Macdonald, JS; Mayer, RJ; O'Rourke, MA | 1 |
Bak, K; Charette, M; Iscoe, N; McCready, D; Quirt, I; Verma, S | 1 |
Cheng, Y; Shen, Y | 1 |
Eriksen, MT; Haffner, J; Wibe, A; Wiig, JN | 1 |
Barnwell, J; Gray, R; Hills, RK; Kerr, DJ; McConkey, C; Williams, NS | 1 |
Ellis, RD; Guthrie, D; Latner, AL; Ross, WM; Skillen, AW; Turner, GA | 1 |
Lamm, DL; Reichert, DF | 1 |
Betzler, M; Heimpel, H; Herfarth, C; Lang, M; Lohrmann, HP; Schlag, P; Schreml, W | 1 |
Gröhn, P; Heinonen, E; Klefström, P; Tarkkanen, J | 1 |
Sagebiel, R; Spitler, LE | 1 |
Justrabo, E; Leclerc, A; Martin, F; Martin, MS; Michel, MF | 1 |
Baker, D; Constable, W; Elkon, D; Rinehart, L | 1 |
Villani, C | 1 |
Brailovsky, CA; Chopra, C; El Kappany, H; Elhilali, M; Nigam, VN | 1 |
Bertino, JR; Cohen, AM; Enker, W; Kelsen, DP; Saltz, L; Tao, Y; Tong, W; Yao, TJ | 1 |
Holmes, EC | 1 |
Fleming, TR; Haller, DG; Laurie, JA; Macdonald, JS; Moertel, CG; Tangen, C | 1 |
Emerson, WA; Fleming, TR; Glick, JH; Haller, DG; Laurie, JA; Macdonald, JS; Moertel, CG; Tangen, CM; Tormey, DC; Ungerleider, JS | 1 |
Estes, NC; Fabian, C; Giri, S | 1 |
Cohen, A; Kemeny, N; Saltz, L | 1 |
Coit, DG; Dickler, MN; Meyers, ML | 1 |
Filho, WD; Lopes, A; Nakagawa, WT; Novaes, PE; Rossi, BM | 1 |
Burger, D; Depisch, D; Greiner, R; Karner, J; Kornek, GV; Kovats, E; Marczell, A; Ritschel, J; Salem, G; Scheithauer, W; Schneeweiss, B; Stöger, F; Vischer, HM | 1 |
Bours, V; Fillet, G; Jerusalem, G | 1 |
Ang, PT; Au, E; Chng, HC; Low, CH; Ng, BK; Seow-Choen, F; Soo, KC | 1 |
Ben Abdesselem, M; Ben Ayed, F; Ben Safta, Z; Benna, F; Boussen, H; Dhouib, R; Dziri, C; el May, M; Gammoudi, A; Hamza, H; Jerbi, G; Kallel, N; Khomsi, F; Najah, N; Rahal, K; Zaouche, A | 1 |
Atkins, JN; Bear, HD; Dimitrov, NV; Fisher, B; Fisher, ER; Glass, AG; Jones, J; Mamounas, E; Rockette, H; Wickerham, DL; Wieand, S; Wolmark, N | 1 |
Barnwell, J; Gray, R; Kerr, DJ; McConkey, C | 1 |
Bleeker, WA; Hermans, J; Mulder, NH; Otter, R; Plukker, JT | 1 |
Anger, Y; Bermann, A; Haack, G; Löffler, T; Porschen, R; Rettig, K; Strohmeyer, G | 1 |
Barylak, E; Cnaan, A; Harris, JE; Mansour, EG; Schutt, AJ; Witte, RS | 1 |
Piedbois, P | 1 |
Kerr, DJ | 1 |
Francini, G; Goldberg, RM; Haller, DG; Jacobson, SD; Labianca, R; Macdonald, JS; Sargent, DJ; Seitz, JF; Shepherd, LE | 1 |
Gutterman, JU; Hersh, EM; Mavligit, GM | 1 |
Amery, WK; Cosemans, J; Gooszen, HC; Lopes Cardozo, E; Louwagie, A; Stam, J; Swierenga, J; Vanderschueren, RG; Veldhuizen, RW | 1 |
Glimelius, B; Påhlman, L | 1 |
Ducreux, M | 1 |
Havemann, K; Pflüger, KH; Rothmund, M | 1 |
Spitler, LE | 1 |
Friedman, MA; Hamilton, JM; Sznol, M | 1 |
Theve, T | 1 |
Porschen, R; Stremmel, W | 1 |
Marx, JL | 1 |
Fleming, TR; Gerstner, JB; Krook, JE; Laurie, JA; Leigh, JE; Malliard, J; McCormack, GW; Moertel, CG; Rubin, J; Wieand, HS | 1 |
Gröhn, P; Heinonen, E; Holsti, L; Holsti, P; Klefström, P | 2 |
Bateman, JR; Chlebowski, RT; Nystrom, S; Reynolds, R; Weiner, JM | 1 |
Bell, PR; Shaw, D; Windle, R | 1 |
Baker, D; Constable, W; Sager, H | 1 |
Csontai, A; Fehér, J; Horváth, J; Romics, I | 1 |
Carey, RW; Harmon, DC; Koh, HK; Lew, RA; Sober, AJ | 1 |
Gail, M; Hill, LD; Holmes, EC | 1 |
10 review(s) available for levamisole and Local Neoplasm Recurrence
Article | Year |
---|---|
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Medical Records; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Analysis; United States | 2004 |
Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma.
Topics: Adjuvants, Immunologic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Humans; Interferon-alpha; Interferon-gamma; Levamisole; Melanoma; Neoplasm Recurrence, Local; Quality of Life; Risk Factors; Skin Neoplasms | 2006 |
Adjuvant therapy of colorectal cancer.
Topics: Adjuvants, Immunologic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colonic Neoplasms; Fluorouracil; Forecasting; Humans; Infusions, Intravenous; Leucovorin; Levamisole; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Portal Vein; Prognosis; Radiotherapy, Adjuvant; Rectal Neoplasms; Survival Rate | 1997 |
Adjuvant therapy of malignant melanoma.
Topics: Adjuvants, Immunologic; Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Drug Approval; Female; Humans; Immunotherapy; Incidence; Interferon-alpha; Interferons; Levamisole; Lymphatic Metastasis; Male; Melanoma; Neoplasm Recurrence, Local; Polymerase Chain Reaction; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate; Tyrosine; United States; United States Food and Drug Administration; Vaccines | 1997 |
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.
Topics: Adenocarcinoma; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Leucovorin; Levamisole; Multivariate Analysis; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Survival Analysis | 2001 |
Immunotherapy of human cancer.
Topics: Adjuvants, Immunologic; Antigens, Neoplasm; Antineoplastic Agents; BCG Vaccine; Epitopes; Humans; Immunity, Cellular; Immunosuppression Therapy; Immunotherapy; Levamisole; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Prognosis; Propionibacterium acnes; RNA; Thymosin; Transfer Factor | 1977 |
The value of adjuvant therapy after radical surgery for colorectal cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; Lomustine; Neoplasm Recurrence, Local; Postoperative Care; Radiography; Radiotherapy Dosage; Sweden | 1992 |
[Adjuvant therapy in colonic carcinoma].
Topics: Carcinoma; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care | 1991 |
5-Fluorouracil plus levamisole: effective adjuvant treatment for colon cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemistry, Clinical; Colonic Neoplasms; Colorectal Neoplasms; Combined Modality Therapy; Drug Evaluation; Fluorouracil; Humans; Immunity, Cellular; Levamisole; Neoplasm Recurrence, Local; Stimulation, Chemical | 1990 |
Adjuvant therapy of cutaneous malignant melanoma: a critical review.
Topics: Bacterial Vaccines; BCG Vaccine; Combined Modality Therapy; Humans; Immunotherapy; Levamisole; Lymph Node Excision; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Propionibacterium acnes; Random Allocation; Research Design; Risk; Skin Neoplasms; Time Factors; Transfer Factor | 1985 |
35 trial(s) available for levamisole and Local Neoplasm Recurrence
Article | Year |
---|---|
LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Topics: AC133 Antigen; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Colorectal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Immunoenzyme Techniques; Levamisole; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Real-Time Polymerase Chain Reaction; Receptors, G-Protein-Coupled; Survival Rate; Tissue Array Analysis | 2016 |
5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis | 2003 |
Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care; Radiotherapy, Adjuvant; Rectal Neoplasms; Survival Analysis | 2003 |
Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Body Weight; Chemotherapy, Adjuvant; Cohort Studies; Colonic Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Obesity; Risk Factors; Survival Rate; Treatment Outcome; United States | 2003 |
Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Humans; Infusions, Intravenous; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Risk Factors; Treatment Outcome | 2004 |
Leucovorin and fluorouracil vs levamisole and fluorouracil as adjuvant chemotherapy in rectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Rectal Neoplasms; Survival Rate; Treatment Outcome | 2004 |
A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Interferon-alpha; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Survival Analysis | 2005 |
Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Diarrhea; Dose-Response Relationship, Drug; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Compliance; Risk Factors; Survival Analysis; Treatment Outcome; Vitamin B Complex | 2005 |
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Vitamin B Complex | 2007 |
Increased breast-cancer recurrence rate after adjuvant therapy with levamisole. A preliminary report. Executive Committee of the Danish Breast Cancer Cooperative Group.
Topics: Adult; Age Factors; Axilla; Biopsy; Breast Neoplasms; Female; Humans; Levamisole; Lymph Nodes; Mastectomy; Menopause; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Risk | 1980 |
Adjuvant chemo(immuno-)-therapy of primary breast cancer with adriamycin-cyclophosphamide (and levamisole)--six-year evaluation.
Topics: Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Levamisole; Mastectomy; Neoplasm Recurrence, Local | 1983 |
A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Immunotherapy; Levamisole; Lymph Node Excision; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Placebos; Prognosis; Random Allocation | 1980 |
A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Female; Floxuridine; Fluorouracil; Humans; Infusions, Parenteral; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Survival Analysis | 1994 |
Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large cell undifferentiated carcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Immunotherapy; Levamisole; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Pneumonectomy; Postoperative Period; Retrospective Studies; Survival Rate | 1994 |
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis | 1995 |
Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Adult; Aged; Antimetabolites, Antineoplastic; Colonic Neoplasms; Disease-Free Survival; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Intraperitoneal; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate; Treatment Outcome | 1998 |
[Adjuvant chemotherapy after curative surgery for non-metastatic colorectal carcinomas (2-year results of 52 cases)].
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome | 1999 |
Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local | 1999 |
Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. QUASAR Collaborative Group.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Therapy, Combination; Fluorouracil; Humans; Leucovorin; Levamisole; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Rectal Neoplasms; Survival Analysis | 2000 |
Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: non-randomised comparison of weekly versus four-weekly schedules--less pain, same gain. QUASAR Colorectal Cancer Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Analysis; Treatment Outcome | 2000 |
Value and cost of follow-up after adjuvant treatment of patients with Dukes' C colonic cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Chemotherapy, Adjuvant; Colonic Neoplasms; Costs and Cost Analysis; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Levamisole; Liver Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Physical Examination; Survival Analysis; Tomography, X-Ray Computed; Ultrasonography | 2001 |
Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01.
Topics: Adjuvants, Immunologic; Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome | 2001 |
Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
Topics: Abdominal Neoplasms; Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Levamisole; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Survival Analysis; Treatment Outcome | 2001 |
A United Kingdom coordinating committee on cancer research study of adjuvant chemotherapy for colorectal cancer: preliminary results.
Topics: Adjuvants, Immunologic; Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colorectal Neoplasms; Double-Blind Method; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Odds Ratio; Prospective Studies | 2001 |
Adjuvant therapy with levamisole in resectable lung cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Levamisole; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Placebos; Time Factors | 1978 |
Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial; Study Group for Bronchogenic Carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Clinical Trials as Topic; Female; Humans; Immunity; Levamisole; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy | 1975 |
The value of adjuvant therapy after radical surgery for colorectal cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; Lomustine; Neoplasm Recurrence, Local; Postoperative Care; Radiography; Radiotherapy Dosage; Sweden | 1992 |
A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma.
Topics: Adult; Aged; Combined Modality Therapy; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Levamisole; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms | 1991 |
[Adjuvant chemotherapy improves chances of survival in curative surgery of colon cancer, Dukes' stage C].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Complications; Retrospective Studies; Survival Rate | 1990 |
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorouracil; Humans; Levamisole; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Patient Compliance; Random Allocation | 1989 |
Levamisole in the treatment of stage II breast cancer. Five-year follow-up of a randomized double-blind study.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Double-Blind Method; Female; Follow-Up Studies; Hematologic Diseases; Humans; Levamisole; Menopause; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Random Allocation | 1985 |
Long-term survival following levamisole or placebo adjuvant treatment of colorectal cancer: a Western Cancer Study Group Trial.
Topics: Adenocarcinoma; Adult; Aged; Clinical Trials as Topic; Colonic Neoplasms; Double-Blind Method; Humans; Levamisole; Middle Aged; Neoplasm Recurrence, Local; Random Allocation; Rectal Neoplasms | 1988 |
Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. II. 5-year results and influence of levamisole.
Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Levamisole; Mastectomy; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Random Allocation | 1987 |
Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer.
Topics: Adult; Aged; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Leukocyte Migration-Inhibitory Factors; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Rectal Neoplasms | 1987 |
A randomized comparison of the effects of adjuvant therapy on resected stages II and III non-small cell carcinoma of the lung. The Lung Cancel Study Group.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Levamisole; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Random Allocation | 1985 |
22 other study(ies) available for levamisole and Local Neoplasm Recurrence
Article | Year |
---|---|
Late Onset of ANCA Vasculitis as a Side Effect of Levamisole Treatment in Nephrotic Syndrome.
Topics: Antibodies, Antineutrophil Cytoplasmic; Arthritis; Celiac Disease; Child, Preschool; COVID-19; COVID-19 Vaccines; Humans; Levamisole; Male; Neoplasm Recurrence, Local; Nephrotic Syndrome; Vasculitis | 2022 |
Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.
Topics: Adjuvants, Immunologic; Aged; Antimetabolites, Antineoplastic; Carcinoma; Cell Adhesion Molecules; Chemotherapy, Adjuvant; Colectomy; Colorectal Neoplasms; DCC Receptor; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Receptors, Cell Surface; Survival Analysis; Treatment Outcome; Tumor Suppressor Proteins | 2004 |
Adaptive design: estimation and inference with censored data in a semiparametric model.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Computer Simulation; Confidence Intervals; Data Interpretation, Statistical; Fluorouracil; Levamisole; Neoplasm Recurrence, Local; Proportional Hazards Models; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome | 2007 |
Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Norway; Patient Selection; Prognosis; Proportional Hazards Models; Radiotherapy, Adjuvant; Rectal Neoplasms; Registries; Survival Rate; Treatment Outcome | 2007 |
Cyclic GMP in urine to monitor the response to ovarian cancer to therapy.
Topics: Creatinine; Cyclic GMP; Cyclophosphamide; Cystadenocarcinoma; Drug Therapy, Combination; Female; Gestonorone Caproate; Humans; Levamisole; Neoplasm Recurrence, Local; Ovarian Neoplasms | 1982 |
Long term protection in bladder cancer following intralesional immunotherapy.
Topics: Adjuvants, Immunologic; Animals; BCG Vaccine; Carcinoma, Transitional Cell; Cell Line; Evaluation Studies as Topic; Glycolipids; Immunization; Immunotherapy; Levamisole; Mice; Mice, Inbred C3H; Mycobacterium bovis; Neoplasm Recurrence, Local; Time Factors; Urinary Bladder Neoplasms | 1984 |
Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Immunotherapy; Levamisole; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy; Radiotherapy Dosage; Random Allocation | 1984 |
Ineffectiveness of levamisole as adjuvant to surgery with two lines of transplanted rat colonic carcinoma.
Topics: Animals; Colonic Neoplasms; Levamisole; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neoplasms, Experimental; Rats | 1981 |
The influence of ICRF-159 and levamisole on the incidence of metastases following local irradiation of a solid tumor.
Topics: Animals; Female; Levamisole; Mice; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Neoplasms, Radiation-Induced; Piperazines; Radiotherapy; Radiotherapy Dosage; Razoxane; Risk | 1981 |
[CEA (carcinoembryonic antigen) in breast cancer. Clinical value].
Topics: Breast Neoplasms; Carcinoembryonic Antigen; Female; Humans; Levamisole; Mastectomy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis | 1981 |
The antitumour activity of maltose tetrapalmitate compared with other immunoadjuvants, and its effectiveness after tumour surgery.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Bacterial Vaccines; BCG Vaccine; Dose-Response Relationship, Immunologic; Glycolipids; Levamisole; Male; Maltose; Neoplasm Recurrence, Local; Neoplasms, Experimental; Palmitates; Postoperative Period; Propionibacterium acnes; Prostatic Neoplasms; Rats; Rats, Inbred Strains | 1980 |
An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer.
Topics: Biomarkers, Tumor; Carcinoembryonic Antigen; Chemotherapy, Adjuvant; Colonic Neoplasms; Cost-Benefit Analysis; Fluorouracil; Humans; Levamisole; Neoplasm Recurrence, Local; Sensitivity and Specificity | 1993 |
Patterns of recurrence for advanced colon cancer modified by whole abdominal radiation and chemotherapy.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Retrospective Studies; Treatment Failure | 1996 |
Radiation and chemotherapy instead of surgery for low infiltrative rectal adenocarcinoma: a prospective trial.
Topics: Abdomen; Adenocarcinoma; Adjuvants, Immunologic; Anal Canal; Antidotes; Antimetabolites, Antineoplastic; Brachytherapy; Cesium Radioisotopes; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Iridium Radioisotopes; Leucovorin; Levamisole; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Peritoneum; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Rectal Neoplasms; Remission Induction; Survival Rate; Treatment Outcome; Treatment Refusal | 1998 |
[How I treat colorectal cancer. I. Prevention and adjuvant treatment].
Topics: Adenocarcinoma; Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Belgium; Chemotherapy, Adjuvant; Colonic Neoplasms; Diet; Fluorouracil; Humans; Leucovorin; Levamisole; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Rectal Neoplasms; Survival Rate | 1998 |
Adjuvant chemotherapy for patients with resected Dukes' C and high-risk B2 colon cancer with fluorouracil and levamisole.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Singapore; Treatment Outcome | 1998 |
Fourth International Conference on Colorectal Cancer: adjuvant treatment of colon cancer--introduction.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Drug Therapy, Combination; Fluorouracil; Humans; Interferon-alpha; Levamisole; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Education as Topic | 2001 |
[Adjuvant treatment of resected colon cancers using a 5-fluorouracil-levamisole combination].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; Neoplasm Recurrence, Local; Rectal Neoplasms; Semustine | 1991 |
[Is levamisole combined with fluorouracil efficient in colorectal cancer?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; Neoplasm Recurrence, Local | 1990 |
Drug availability is an issue for cancer patients, too.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorouracil; Humans; Levamisole; Neoplasm Recurrence, Local | 1989 |
The influence of levamisole and hyperthermia on the incidence of metastases from an X-irradiated tumor.
Topics: Animals; Female; Hyperthermia, Induced; Levamisole; Mice; Mice, Inbred C3H; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sarcoma, Experimental | 1986 |
Effect of levamisol on cellular and humoral immune reactivity and on recurrences in patients with bladder papilloma.
Topics: Aged; Female; Humans; Immunoglobulin G; Immunotherapy; Leukocyte Count; Levamisole; Lymphocyte Activation; Male; Middle Aged; Neoplasm Recurrence, Local; Papilloma; Rosette Formation; Tuberculin Test; Urinary Bladder Neoplasms | 1985 |